Literature DB >> 22798269

Quantification of TRPV1 protein levels in rat tissues to understand its physiological roles.

Ping Han1, Alla V Korepanova, Melissa H Vos, Robert B Moreland, Mark L Chiu, Connie R Faltynek.   

Abstract

Transient receptor potential subfamily V, member 1 (TRPV1) is a nonselective cation channel expressed in both the peripheral and central nervous systems (CNS). TRPV1 protein levels in rat tissues were determined under normal and pain states using enzyme-linked immunosorbent assay. In naive rats, brain TRPV1 protein concentrations ranged from 1.5 to 4 ng/mg in hippocampus, cortex, hypothalamus, and cerebellum. Rat spinal cord TRPV1 protein levels were 40-50 ng/mg in L1-L5 of the lumbar regions, but increased to 97 ± 9.3 ng/mg toward the end of the lumbar region (L6-S1). In the complete Freund's adjuvant (CFA)-induced inflammatory pain model, TRPV1 protein level significantly increased on both the contralateral (36.5 %, p < 0.05) and ipsilateral (31.4 %, p < 0.05) L4-L6 dorsal root ganglia (DRG). TRPV1 protein levels also increased 33.3 % (p < 0.05) on the ipsilateral sciatic nerve, but no significant change in the lumbar spinal cord of CFA rats. In the monoiodoacetate-induced rat knee joint pain model, TRPV1 protein level was significantly reduced in the ipsilateral L3-L5 DRG (33.3 %, p < 0.01), no significant difference was detected in the lumbar region of the spinal cord. Quantitative determination of TRPV1 protein levels may help to elucidate the TRPV1 physiological roles and regulatory mechanisms in various pain states.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798269     DOI: 10.1007/s12031-012-9849-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  56 in total

1.  TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.

Authors:  M Cui; P Honore; C Zhong; D Gauvin; J Mikusa; G Hernandez; P Chandran; A Gomtsyan; B Brown; E K Bayburt; K Marsh; B Bianchi; H McDonald; W Niforatos; T R Neelands; R B Moreland; M W Decker; C-H Lee; J P Sullivan; C R Faltynek
Journal:  J Neurosci       Date:  2006-09-13       Impact factor: 6.167

2.  Vanilloid receptor VR1-positive afferents are distributed differently at different levels of the rat lumbar spinal cord.

Authors:  S J Hwang; J G Valtschanoff
Journal:  Neurosci Lett       Date:  2003-09-25       Impact factor: 3.046

3.  Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.

Authors:  J B Davis; J Gray; M J Gunthorpe; J P Hatcher; P T Davey; P Overend; M H Harries; J Latcham; C Clapham; K Atkinson; S A Hughes; K Rance; E Grau; A J Harper; P L Pugh; D C Rogers; S Bingham; A Randall; S A Sheardown
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

4.  A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.

Authors:  Prisca Honore; Carol T Wismer; Joe Mikusa; Chang Z Zhu; Chengmin Zhong; Donna M Gauvin; Arthur Gomtsyan; Rachid El Kouhen; Chih-Hung Lee; Kennan Marsh; James P Sullivan; Connie R Faltynek; Michael F Jarvis
Journal:  J Pharmacol Exp Ther       Date:  2005-04-18       Impact factor: 4.030

5.  Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord.

Authors:  Bruce R Bianchi; Rachid El Kouhen; Jun Chen; Pamela S Puttfarcken
Journal:  Eur J Pharmacol       Date:  2010-02-11       Impact factor: 4.432

Review 6.  CGRP and its receptors provide new insights into migraine pathophysiology.

Authors:  Tony W Ho; Lars Edvinsson; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2010-09-07       Impact factor: 42.937

7.  Heteromerization and colocalization of TrpV1 and TrpV2 in mammalian cell lines and rat dorsal root ganglia.

Authors:  A Richard Rutter; Qing-Ping Ma; Mathew Leveridge; Timothy P Bonnert
Journal:  Neuroreport       Date:  2005-11-07       Impact factor: 1.837

8.  Proton inhibition of [3H]resiniferatoxin binding to vanilloid (capsaicin) receptors in rat spinal cord.

Authors:  A Szallasi; P M Blumberg; J M Lundberg
Journal:  Eur J Pharmacol       Date:  1995-04-28       Impact factor: 4.432

9.  Treatment of trigeminal ganglion neurons in vitro with NGF, GDNF or BDNF: effects on neuronal survival, neurochemical properties and TRPV1-mediated neuropeptide secretion.

Authors:  Theodore J Price; Michael D Louria; Damaries Candelario-Soto; Gregory O Dussor; Nathanial A Jeske; Amol M Patwardhan; Anibal Diogenes; Amanda A Trott; Kenneth M Hargreaves; Christopher M Flores
Journal:  BMC Neurosci       Date:  2005-01-24       Impact factor: 3.288

10.  Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy.

Authors:  Paul Facer; Maria A Casula; Graham D Smith; Christopher D Benham; Iain P Chessell; Chas Bountra; Marco Sinisi; Rolfe Birch; Praveen Anand
Journal:  BMC Neurol       Date:  2007-05-23       Impact factor: 2.474

View more
  12 in total

1.  Biphasic modulation by mGlu5 receptors of TRPV1-mediated intracellular calcium elevation in sensory neurons contributes to heat sensitivity.

Authors:  T Masuoka; T Nakamura; M Kudo; J Yoshida; Y Takaoka; N Kato; T Ishibashi; N Imaizumi; M Nishio
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

2.  Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling.

Authors:  Anna H C Vlot; Wilhelmus E A de Witte; Meindert Danhof; Piet H van der Graaf; Gerard J P van Westen; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2017-12-04       Impact factor: 4.009

3.  Compartment-specific modulation of GABAergic synaptic transmission by TRPV1 channels in the dentate gyrus.

Authors:  Andrés E Chávez; Vivian M Hernández; Alma Rodenas-Ruano; C Savio Chan; Pablo E Castillo
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

4.  New transient receptor potential vanilloid subfamily member 1 positron emission tomography radioligands: synthesis, radiolabeling, and preclinical evaluation.

Authors:  Daisy van Veghel; Jan Cleynhens; Larry V Pearce; Ian A DeAndrea-Lazarus; Peter M Blumberg; Koen Van Laere; Alfons Verbruggen; Guy Bormans
Journal:  ACS Chem Neurosci       Date:  2013-02-19       Impact factor: 4.418

Review 5.  Cerebellar endocannabinoids: retrograde signaling from purkinje cells.

Authors:  Païkan Marcaggi
Journal:  Cerebellum       Date:  2015-06       Impact factor: 3.847

6.  Red peppers with moderate and severe pungency prevent the memory deficit and hepatic insulin resistance in diabetic rats with Alzheimer's disease.

Authors:  Hye Jeong Yang; Dae Young Kwon; Min Jung Kim; Suna Kang; Na Rang Moon; James W Daily; Sunmin Park
Journal:  Nutr Metab (Lond)       Date:  2015-03-08       Impact factor: 4.169

7.  Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles.

Authors:  József Kun; István Szitter; Agnes Kemény; Anikó Perkecz; László Kereskai; Krisztina Pohóczky; Aron Vincze; Szilárd Gódi; Imre Szabó; János Szolcsányi; Erika Pintér; Zsuzsanna Helyes
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

8.  Targeting TRPV1 to relieve motion sickness symptoms in mice by electroacupuncture and gene deletion.

Authors:  Chanya Inprasit; Yi-Wen Lin; Chun-Ping Huang; Shu-Yih Wu; Ching-Liang Hsieh
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

Review 9.  Perspectives of TRPV1 Function on the Neurogenesis and Neural Plasticity.

Authors:  R Ramírez-Barrantes; C Cordova; H Poblete; P Muñoz; I Marchant; F Wianny; P Olivero
Journal:  Neural Plast       Date:  2016-01-05       Impact factor: 3.599

10.  TRPV1 regulates excitatory innervation of OLM neurons in the hippocampus.

Authors:  Joaquin I Hurtado-Zavala; Binu Ramachandran; Saheeb Ahmed; Rashi Halder; Christiane Bolleyer; Ankit Awasthi; Markus A Stahlberg; Robin J Wagener; Kristin Anderson; Ryan M Drenan; Henry A Lester; Julie M Miwa; Jochen F Staiger; Andre Fischer; Camin Dean
Journal:  Nat Commun       Date:  2017-07-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.